Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)

BACKGROUND: Treatment Resistant Bipolar Depression (TRBD) is a major contributor to the burden of disease associated with Bipolar Disorder (BD). Treatment options for people experiencing bipolar depression are limited to three interventions listed by National Institute for Health and Care: lamotrigi...

Descripción completa

Detalles Bibliográficos
Autores principales: Azim, Lumbini, Hindmarch, Paul, Browne, Georgiana, Chadwick, Thomas, Clare, Emily, Courtney, Paul, Dixon, Lyndsey, Duffelen, Nichola, Fouweather, Tony, Geddes, John R., Goudie, Nicola, Harvey, Sandy, Helter, Timea, Holstein, Eva-Maria, Martin, Garry, Mawson, Phil, McCaffery, Jenny, Morriss, Richard, Simon, Judit, Smith, Daniel, Stokes, Paul R. A., Walker, Jenn, Weetman, Chris, Wolstenhulme, Faye, Young, Allan H., Watson, Stuart, McAllister-Williams, R. Hamish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256234/
https://www.ncbi.nlm.nih.gov/pubmed/34225686
http://dx.doi.org/10.1186/s12888-021-03322-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256234/
https://www.ncbi.nlm.nih.gov/pubmed/34225686
http://dx.doi.org/10.1186/s12888-021-03322-y

Ejemplares similares